Spread the love“`html In today’s relentless business environment, the phrase “time is money” isn’t just a cliché; it’s a ...
AB Science has discontinued a large, late-stage trial testing its oral therapy masitinib in people with progressive multiple sclerosis. The trial was stopped due to a change in company priorities, not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results